BCR-ABL, a fusion between the breakpoint cluster region and ABL kinase, is the major driver of leukemogenesis in chronic myelogenous leukemia (CML). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.